News
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
2h
Bizcommunity on MSNDanish weight-loss drug Wegovy debuts in South Africa, challenging Eli Lilly
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.
3h
Everyday Health on MSNFDA Raises Safety Concerns About Compounded GLP-1 Weight Loss Drugs
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
This article covers key health news including Primary Health Properties securing a takeover bid for Assura, Novo Nordisk's ...
Novo Nordisk (NYSE: NVO) is quite the divisive stock among both investors and analysts these days. Although its high-profile ...
New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
Scientists have uncovered a hidden molecule in DNA that helps control fat storage, offering hope for a new kind of obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results